Skip to content

#genetic disorders

39 public questions tagged with this topic.

What is the primary genetic cause of hemophilia?

Hemophilia is a sex-linked recessive disorder caused by a mutation in the X chromosome. This follows from NCERT principle where relation explains outcome clearly for students.

Ref: NCERT Biology Textbook for Class XI and XII (Botany section), Chapter: Biology - Botany portion covering relevant concept, Topic: Plant structure, physiology and applications.

Which condition is caused by mutations in Pax6?

Mutations in PAX6 transcription factor cause aniridia, congenital absence or severe hypoplasia of iris, accompanied by corneal opacification, cataracts, foveal hypoplasia, and nystagmus. Pax6 continues expression in iris, cornea, retina throughout development maintaining ocular progenitor gene networks. Dominant haploinsufficiency reduces DNA binding to target promoters. Cataract alone typically results from crystallin mutations, retinal detachment from other causes, myopia polygenic. Aniridia represents classic dosage-sensitive phenotype of PAX6 linked to 11p13 deletion, demonstrating pleiotr

Ref: NCBI Bookshelf, Molecular Biology of Eye: PAX6 mutations causing aniridia and ocular anomalies.

Mutation in ACA gene results in:

ACA establishes positive feedback loop of cAMP signaling that organizes collective movement. Mutants lacking functional ACA fail to synthesize pulses, therefore no extracellular cAMP wave propagates, cells do not polarize, stream, or form mounds, and developmental program arrests early. Intracellular cAMP remains low, preventing induction of early genes like discoidin and contact site A. Phenotype includes lack of aggregation territory, no slug formation despite starvation. Normal aggregation patterns require ACA-mediated relay; excessive aggregation would require increased cyclase activity, w

Ref: Science, ACA null phenotype - failure to aggregate, cAMP pulse rescue and developmental arrest.

Which disease was among the first targets of gene therapy?

Adenosine deaminase deficiency autosomal recessive SCID became earliest successful gene therapy target due biological features favoring correction. Enzyme chromosome 20q13.12 deaminates adenosine to inosine and deoxyadenosine to deoxyinosine, deficiency leads accumulation deoxyadenosine converted deoxycytidine kinase to dATP elevated dATP allosterically inhibits ribonucleotide reductase essential dNTP synthesis DNA replication lymphocyte clonal expansion triggers apoptosis intrinsic pathway resulting absent T B NK cells. Lymphoid lineage provides selective advantage because corrected cells det

Ref: Lancet ADA First Gene Therapy NEJM 1990; NCBI SCID Gene Therapy History; NCERT Biotechnology Applications ADA Chapter 12.

Gene augmentation therapy (GAT) is used to:

Gene augmentation alias addition therapy provides supplemental functional copy gene compensating recessive loss-of-function mutation where endogenous loci produce truncated or misfolded protein rapidly degraded proteasome or nonsense-mediated decay. Delivered cDNA lacks introns and native regulatory elements codon-optimized enhancing translation and CpG depleted reducing TLR9 activation expressed under heterologous constitutive promoter chicken beta-actin with CMV enhancer or tissue-specific transthyretin promoter driving strong transcription independent defective locus that remains present bu

Ref: NIH Gene Augmentation Therapy Strategy; Watson Molecular Biology Gene Augmentation Chap 15; NCBI Bookshelf Gene Addition https://www.ncbi.nlm.nih.gov/books/NBK21981/.

Which of the following is a characteristic of lysosomal storage disorders?

Lysosomal storage disorders form a group of about seventy rare inherited metabolic diseases sharing unifying pathophysiology despite diverse enzyme defects. Mutations in genes encoding lysosomal acid hydrolases, accessory activator proteins GM2 activator and saposins, sulfatases requiring formylglycine modification by SUMF1, or lysosomal integral membrane transporters such as cystinosin and sialin impair specific catabolic steps. Because residual enzyme activity falls below threshold, typically less than ten percent of normal, undegraded macromolecular substrates such as sphingolipids, mucopol

Ref: Parenti et al., Nature Reviews Drug Discovery 2015: Lysosomal Storage Disorders – Substrate Accumulation.